Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 67, 2012 - Issue 6
34
Views
0
CrossRef citations to date
0
Altmetric
Congress Articles

WHERE DOES POLYMYALGIA RHEUMATICA END AND GIANT CELL ARTERITIS BEGIN? LESSONS FROM POSITRON EMISSION TOMOGRAPHY STUDIES

Pages 389-393 | Published online: 25 Jul 2014

REFERENCES

  • Paulley JW, Hughes JP. Giant cell arteritis, or arteritis of the aged. BMJ 1960; 2: 1562–1567.
  • Wilske KR, Healey LA. Polymyalgia rheumatica: a manifestation of giant cell arte-ritis. Ann Intern Med 1967; 66: 77–91.
  • Cantini F, Niccoli L, Storri L, et al. Are polymyalgia rheumatica and giant cell arteritis the same disease? Semin Arthritis Rheum 2004; 33: 294–301.
  • Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arte-ritis. Lancet 2008; 372: 234–245.
  • Healey LA. Polymyalgia rheumatica and seronegative rheumatoid arthritis may be the same entity. J Rheumatol 1992; 19: 270–272.
  • Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Oilier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheu-matica. Semin Arthritis Rheum 2003; 33: 38–48.
  • Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathof-physiology, geoepidemiology and treatment. Autoimmunity reviews 2012; 11: A544–554.
  • Backhaus M, Burmester GR, Gerber T, et al. Guidelines for musculoskeletal ultra-sound in rheumatology. Ann Rheum Dis 2001; 60: 641–649.
  • Pavlica P. Barozzi L, Salvarani C, Cantini F, Olivieri I. Magnetic resonance imaging in the diagnosis of PMR. Clin Exp Rheumatol 2000; 18: 538–539.
  • Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. Rheu-matology 2007; 46: 672–677.
  • Salvarani C, Barozzi L, Cantini F, et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008; 67: 758–761.
  • Adams H, Raijmakers P. Smulders Y. Polymyalgia rheumatica and interspinous FDG uptake on PET/CT. Clin Nucl Med 2012; 37: 502–505.
  • Camellino D, Cimmino MA. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology 2012; 51: 77–86.
  • Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 2006; 55: 985–989.
  • Salvarani C, Pipitone N, Versari A, Hunder GG. Clinical features of polymyalgia rheumatica and giant cell arteritis. Nat Rev Rheumatol 2012; 8:509–521.
  • Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis. Arthritis Rheum 1999; 42: 844–853.
  • Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Int Med 1994; 121: 484–491.
  • Chatelain D, Duhaut P. Loire R, et al. Small-vessel vasculitis surrounding an unin-flamed temporal artery. A new diagnostic criterion for polymyalgia rheumatica? Arthritis Rheum 2008; 58: 2565–2573.
  • Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38: 352–359.
  • Tato F, Hoffmann U. Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 2006; 44: 176–182.
  • Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122: 502–507.
  • Garcia-Martinez A, Hernandez-Rodriguez J, Arguis P. et al. Development of aor-tic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008; 59: 422–430.
  • Brack A, Martinez-Taboada V. Stanson A, Goronzy JJ, Weyand CM. Disease pat-tern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42: 311–317.
  • Blockmans D, Knockaert D, Maes A, et al. Clinical value of (18F)fluoro-deoxyglu-cose positron emission tomography for patients with fever of unknown origin. Clin Inf Dis 2001; 32:191–196.
  • Blockmans D, Maes A, Stroobants S, et al. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology 1999; 42: 311–317.
  • Blockmans D, Stroobants S, Maes A, Mortelmans L Positron emission tomogra-phy in giant cell arteritis and polymyalgia rheumatica: evidence for inflamma-tion of the aortic arch. Am J Med 2000; 108: 246–249.
  • Blockmans D, De Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006; 55:131–137.
  • Blockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluo-rodeoxyg lucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 2008; 47: 1179–1184.
  • Schillaci G, Bartoloni E, Pucci G, et al. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment. Ann Rheum Dis 2012; 71: 1151–1156.
  • Maksimowicz-McKennon K, Clark TM, Hoffman GS. Takayasu arteritis and giant cell arteritis. A spectrum within the same disease? Medicine 2009; 88:221–226.
  • Grayson PC, Maksimowicz-McKinnon K, Clark TM, et al. Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis 2012; 71: 1329–1334.
  • Dasgupta B, Cimmino MA, Kremers HM, et al. 2012 Provisional classification criteria for polymyalgia rheumatica. A European League Against Rheumatism/ American College of Rheumatology collaborative initiative. Arthritis Rheum 2012; 64: 943–954.
  • Chuang TY, hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann intern Med 1982; 97: 672–680.
  • Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for syno-vitis. Semin Arthritis Rheum 1984; 13: 322–328.
  • Bird HA, Esselinclot W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434–439.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.